Total cases | 36 |
Total patients | 32 |
Age (years) | 57.9 ± 13.7 |
Male | 5 (13.9) |
Total aneurysms treated | 40 |
Aneurysm size, average | 6.9 mm |
Anterior circulation | 38 (95) |
Cavernous | 5 (12.5) |
Clinoidal | 4 (10.0) |
Ophthalmic | 13 (32.5) |
Communicating | 8 (20.0) |
Anterior communicating | 6 (15.5) |
Distal ACA | 2 (5) |
Posterior circulation | 2 (10) |
PICA | 1 (2.5) |
Vertebral | 1 (2.5) |
Triaxial system | 36 |
Guide sheath | |
NeuronMax | 30 (83.3) |
Select catheter | |
JB-1 | 31 (86.1) |
Guide catheter | |
Catalyst 058 | 36 (100) |
Microcatheter | |
Marksman 0.027 inch | 3 (8.3) |
Via 0.027 inch | 34 (94.4) |
Other catheters | 11 (30.6) |
Pipeline embolization devices (33 cases, 32 patients) | 40 |
WEB devices (2 cases) | 2 |
Coils (3 cases) | 32 |
Cervical tortuosity | 15 (41.2%) |
Guide catheter position | |
Cervical ICA | 0 (0) |
Petrous ICA | 1 (2.7) |
Proximal cavernous ICA | 6 (16.7) |
Distal cavernous/clinoidal ICA | 24 (66.7) |
Ophthalmic | 1 (2.7) |
Communicating | 1 (2.7) |
ACA | 1 (2.7) |
Distal vertebral | 2 (5.4) |
Clinical success | |
Catalyst tracked to target | 36 (100) |
Successful treatment | 36 (100) |